Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore public issue comprises a fresh issue of Rs 200 crore and an offer for sale (OFS) of Rs 739.70 crore by existing shareholders. The molecular diagnostics company plans to use the proceeds to expand R&D infrastructure, manufacturing capabilities, and strengthen its healthcare diagnostics portfolio.
The Indian quick-service restaurant (QSR) sector is entering a favourable phase after a challenging period, according to Motilal Oswal Financial Services. The brokerage believes easing valuations, improving operational trends, and long-term consumption growth could support a recovery in QSR stocks. It remains selective in the space and highlights Jubilant FoodWorks, Sapphire Foods India, Westlife Foodworld, and Devyani International as key picks.
Axis Direct expects the Nifty to climb to 28,615 by December in its bull-case scenario, driven by a revival in private capex, resilient domestic demand and improving earnings. The brokerage remains overweight on BFSI, healthcare and capital goods, while cautioning that global risks and elevated valuations could trigger near-term volatility.
HSBC expects India to attract up to $25 billion in foreign equity inflows if global investors rebalance portfolios away from volatile AI-driven markets. The brokerage has identified 10 preferred stocks, including ICICI Bank, Titan, M&M and Adani Ports, citing strong earnings visibility, domestic demand and structural growth drivers.
Chinese equities climbed to a one-week high, led by semiconductor stocks, while Hong Kong shares edged higher. Improving global risk sentiment amid easing Middle East tensions also supported markets. Chip stocks gained after reports that Samsung Electronics and SK Hynix are evaluating Chinese chipmaking equipment to reduce exposure to potential tighter US export controls.
Japan’s Nikkei surged over 3%, led by AI-related stocks tracking Wall Street’s overnight rally. Strong corporate earnings and upgraded forecasts further lifted sentiment, while softer oil prices and lower US Treasury yields also supported markets amid hopes of an Iran-related deal.
Chinese optical stocks tumbled after a Reuters report said the Trump administration was considering a ban on U.S. imports of new Chinese data centre components. Export-focused firms led the decline, while domestic chipmakers gained. Analysts said the proposed move reflects escalating U.S.-China technology tensions and supply chain realignment.
Several Nifty 50 stocks are now trading at significant discounts to historical averages. Bharti Airtel and Tata Consultancy Services show a 36% discount. Infosys trades at a 29% discount, while Apollo Hospitals is at 33%. Trent, the retail arm of Tata Group, is trading at a 27% discount. These sharp deratings present attractive opportunities for long-term investors.
The OFS opened for non-retail investors on August 4, and saw strong participation. The offer was oversubscribed more than 3 times its offer size. It now opens for retail investors today.
While the near-term outlook remains clouded by inflation concerns and margin pressures, Rakesh Vyas, CIO & Portfolio Manager at Quest Investment Managers, believes the underlying earnings story for India remains firmly intact.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.